Further, we adopted TIMER to examine the relationship of CRIM1 with invading immune cells in breast cancer, consisting of CD4+ T-cells, neutrophils, CD8+ T-cells, macrophage M1, B-cells, NK, endothelial cells, and Tregs. This evidence concerns the gene CRIM1 and breast carcinoma.